Agreement


Skye Bioscience Reports that Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement with Skye

August 21st, 2022 - Ryan Allway

San Diego, California, August 19, 2022 — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders of Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (CSE: EMH; OTCQB: EMHTF) today approved the proposed plan of arrangement (the “Arrangement”) with Skye, with approval […]

Irwin Naturals Begins Rollup of Psychedelic Mental Health Clinics

February 9th, 2022 - Ryan Allway

LOS ANGELES, Feb. 09, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has taken the first step in the execution of its ketamine clinic rollup strategy – a move the Company says is motivated by an intention to become the world’s largest chain […]

Eden Empire Announces Partner to Lead Charge in Michigan Franchise Expansion

January 27th, 2022 - Ryan Allway

VANCOUVER, British Columbia and BATTLE CREEK, Mich., Jan. 27, 2022 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden Empire”) is pleased to announce that it has signed an agreement (the “Agreement”) with an arm’s length third-party (the “Partner”) to assist in expanding the EDEN franchise across the State of Michigan. The […]

Audacious Enters Definitive Agreement With Golden Triangle Health

January 12th, 2022 - Ryan Allway

Agreement marks the first commercial shipment of CBD hemp seeds to Asia by a North American company and kicks off AUDACIOUS’ revenue generating initiatives in the region.    LAS VEGAS, Jan. 12, 2022 /CNW/ – AUDACIOUS CEO Terry Booth is proud to announce that AUDACIOUS has entered into a definitive agreement with Golden Triangle Health (GTH) on a strategic partnership that […]

Sundial Growers and Alcanna Inc. Announce the Agreement to Revised Consideration Under the Proposed Plan of Arrangement

January 6th, 2022 - Ryan Allway

CALGARY, AB and EDMONTON, AB, Jan. 6, 2022 /CNW/ – Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial“) and Alcanna Inc. (TSX: CLIQ) (“Alcanna“) announce that Sundial has agreed to improve the consideration to be provided to Alcanna shareholders (the “Alcanna Shareholders“) for their common shares of Alcanna (each, an “Alcanna Share“) pursuant to the previously announced plan of arrangement under the Canada […]

Teva Israel enters medical cannabis market with new partnership

December 26th, 2021 - Ryan Allway

JERUSALEM, Dec 26 (Reuters) – (This December 26 story was corrected after company clarified that the deal is with Teva Israel) The Israeli unit of drugmaker Teva Pharmaceutical Industries (TEVA.TA) said on Sunday it was entering the medical cannabis market by signing an exclusive and mutual collaboration agreement with another Israeli company, Tikun Olam-Cannbit (TKUN.TA) Under the agreement, […]

Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics

December 23rd, 2021 - Ryan Allway

TORONTO, ON / December 23, 2021 / Novamind Inc. (CSE: NM | OTCQB: NVMDF | FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, has signed a definitive agreement (the “Agreement”) to acquire Arizona-based Foundations for Change, PLC (“Foundations”), a mental health practice specialized in ketamine-assisted psychotherapy, from its sole […]

Craftport Cannabis Provides Update Regarding Pitt Meadows Facility

December 13th, 2021 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – December 13, 2021) – Craftport Cannabis Corp. (CSE: CFT) (“Craftport” or the “Company”) today announced the following regarding the Pitt Meadows facility (“Pitt Meadows”). Pitt Meadows is owned by 1161750 B.C Ltd. (“1161”), which is 51% owned by Craftport.   Termination of Cultivation Agreements Pitt Meadows had entered into two […]

Chalice Brands Ltd. Announces Flagship Superstore and Relationship with Aventine Property Group

December 8th, 2021 - Ryan Allway

PORTLAND, Ore., Dec. 08, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE:CHAL) (OTCQB:CHALF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, is pleased to announce it has successfully completed an agreement (the “Agreement”) to lease a retail property located in Portland, Oregon from Aventine Property Group, […]

Australis Provides Commercial Update

October 5th, 2021 - Ryan Allway

Alps Enters into Initial $1.4 Million Engagement with Pure Harvest Smart Farms   1,000,000 sq. ft. High-Tech Growing Solution to Supply the Sultan Center, Kuwait’s Leading   LAS VEGAS, Oct. 5, 2021 /CNW/ – Terry Booth, CEO, is proud to announce – Australis Capital Inc., (CSE: AUSA) (OTC: AUSAF) (“AUSA”),announced today that its majority owned subsidiary ALPS has entered into an agreement […]

Delta 9 Achieves Milestone in Agreement with Element Cannabis Group

September 15th, 2021 - Ryan Allway

WINNIPEG, Manitoba, Sept. 15, 2021 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce that it has completed its final services milestone under an agreement with Alberta based cultivation and processing partner, Element GP Inc. (“Element”). Element is an arm’s length third party in […]

HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies

August 25th, 2021 - Ryan Allway

The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, recently signed […]

Goodness Growth Holdings Signs Definitive Agreement to Acquire Charm City Medicus Dispensary in Baltimore, Maryland

July 9th, 2021 - Ryan Allway

– Transaction will improve scale in Maryland’s medical cannabis market by expanding retail dispensary footprint – – Company expects to transition Charm City Medicus to Green Goods™ retail dispensary brand post-closing –     MINNEAPOLIS, July 9, 2021 /PRNewswire/ — Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and […]

Gage Growth Corp. and Wiz Khalifa’s Khalifa Kush Announce Partnership

July 7th, 2021 - Ryan Allway

DETROIT, July 7, 2021 /PRNewswire/ – Today, Gage Growth Corp. (“Gage” or the “Company”) (CSE: GAGE), a leading high-quality premium cannabis brand and operator in Michigan, announced their exclusive partnership agreement with multi-platinum-selling, GRAMMY® Award and Golden Globe® Award-nominated recording artist Wiz Khalifa’s brand, Khalifa Kush (“KK”), to develop and launch a line of premium cannabis products in the state of Michigan. Khalifa […]

MYM Shareholders Approve Plan of Arrangement with IM Cannabis

July 5th, 2021 - Ryan Allway

VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) — MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”), is pleased to announce that, at its special meeting (the “MYM Meeting”) of shareholders of MYM (“MYM Shareholders”), MYM Shareholders approved the plan of arrangement (the “Arrangement”) with IM Cannabis Corp. (“IMC”) originally announced April 1, […]

Agreement Resolves Commission Concerns Regarding Agreements Made by Previous Management, Clears Path for Retail Licensure

June 18th, 2021 - Ryan Allway

PHOENIX, June 18, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“ TILT” or the “ Company ”) ( CSE: TILT ) ( OTCQX: TLLTF ), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced it has reached an agreement with the Massachusetts Cannabis Control Commission (“ CCC ”) resolving concerns of the CCC and […]

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership.

June 17th, 2021 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – June 17, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon”), a biotechnology company focused on developing psychedelic medicines to treat addiction, and Silo Wellness Inc. (CSE: SILO) (OTC: SILFF) (FSE:3K70) (“Silo Wellness”), a functional and psilocybin mushroom company and psychedelic wellness retreats operator, have signed a referral agreement (the “Agreement”), […]

The Supreme Cannabis Company, Inc. Announces Shareholder Approval of Arrangement with Canopy Growth Corporation

June 10th, 2021 - Ryan Allway

TORONTO, June 10, 2021 /CNW/ – The Supreme Cannabis Company, Inc. (“Supreme” or the “Company” or “we“) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is pleased to announce that, at its special meeting (the “Supreme Meeting“) of shareholders of Supreme (“Supreme Shareholders“), Supreme Shareholders approved the plan of arrangement (the “Arrangement“) with Canopy Growth Corporation (“Canopy“), pursuant to which, […]

Ayurcann Holdings Signs Partnership Agreement with Kindred Partners to Enter Canadian Recreational Market

May 12th, 2021 - Ryan Allway

Toronto, May 12th, 2021: Kindred to bring the up-and-coming company’s cannabis products to locations across Canada   Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products as a strategic partner to other LP’s in […]

Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brazil

April 15th, 2021 - Ryan Allway

TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness”) (CSE: SILO) (FRA:3K70), a wellness company in the psychedelics and functional mushroom marketplaces announced today that through its wholly-owned subsidiary, it has signed a binding Letter of Intent (LOI) for a multi-year patent licensing agreement with Jungle Med Inc. (“Jungle Med”), a human […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading